Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease
Clinical trial NCT02472665 · WITHDRAWN
Trial details
- NCT number
- NCT02472665
- Sponsor
- Grifols Therapeutics LLC
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2024-12-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.